A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults
Status:
Recruiting
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The main goal of this clinical trial is to evaluate the safety, tolerability and
pharmacokinetics (PK) profiles* of MDI-1228_mesylate Ophthalmic Solution in healthy adult
participants.
Participants will receive either of the following treatment:
- MDI-1228_mesylate Ophthalmic Solution, or
- Placebo**
Researchers will observe any changes in heath (if any) in participants receiving the study
treatment to evaluate the safety and tolerability*** of the study drug. Researchers will also
collect several blood samples from participants to study PK profiles of the drug.
Note:
- PK profiles: how the drug interacts with the body. **placebo: a harmless substance that
contains no active agents. ***tolerability: how well you can tolerate the drug.